MA42238A - Procédés de diagnostic du cancer de la vessie - Google Patents
Procédés de diagnostic du cancer de la vessieInfo
- Publication number
- MA42238A MA42238A MA042238A MA42238A MA42238A MA 42238 A MA42238 A MA 42238A MA 042238 A MA042238 A MA 042238A MA 42238 A MA42238 A MA 42238A MA 42238 A MA42238 A MA 42238A
- Authority
- MA
- Morocco
- Prior art keywords
- bladder cancer
- cancer diagnosis
- diagnosis methods
- methods
- bladder
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2523/00—Reactions characterised by treatment of reaction samples
- C12Q2523/10—Characterised by chemical treatment
- C12Q2523/125—Bisulfite(s)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1511152.9A GB201511152D0 (en) | 2015-06-24 | 2015-06-24 | Method of diagnosing bladder cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA42238A true MA42238A (fr) | 2018-05-02 |
Family
ID=53784470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA042238A MA42238A (fr) | 2015-06-24 | 2016-06-24 | Procédés de diagnostic du cancer de la vessie |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11473148B2 (fr) |
| EP (1) | EP3314016B1 (fr) |
| JP (2) | JP7002334B2 (fr) |
| CN (1) | CN108350504B (fr) |
| AU (1) | AU2016283063B2 (fr) |
| GB (1) | GB201511152D0 (fr) |
| MA (1) | MA42238A (fr) |
| WO (1) | WO2016207656A1 (fr) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018213550A1 (fr) * | 2017-05-18 | 2018-11-22 | Genomic Health, Inc. | Méthodes d'analyse pour la détection de méthylation d'adn et de mutation à des fins de surveillance du cancer de la vessie |
| WO2019068082A1 (fr) * | 2017-09-29 | 2019-04-04 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Biomarqueurs de méthylation d'adn pour le diagnostic du cancer |
| KR20250117473A (ko) * | 2017-11-30 | 2025-08-04 | 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 | 유방암 검출방법 |
| GB2587939B (en) | 2018-04-02 | 2023-06-14 | Grail Llc | Methylation markers and targeted methylation probe panels |
| CN108588219B (zh) * | 2018-04-19 | 2021-10-26 | 安徽达健医学科技有限公司 | 一种用于早期膀胱癌检测的试剂盒及其使用方法 |
| AU2019300987B2 (en) * | 2018-07-11 | 2026-02-05 | Stichting Amsterdam UMC | Urine DNA methylation markers for bladder cancer |
| CA3111887A1 (fr) | 2018-09-27 | 2020-04-02 | Grail, Inc. | Marqueurs de methylation et panels de sondes de methylation ciblees |
| EP3880847B1 (fr) * | 2018-11-16 | 2025-09-03 | Oslo Universitetssykehus HF | Procédés et compositions de caractérisation du cancer de la vessie |
| CN111206093A (zh) * | 2018-11-21 | 2020-05-29 | 立森印迹诊断技术（无锡）有限公司 | 一种用于检测浸润性膀胱癌的标志物及其应用 |
| CA3127762A1 (fr) * | 2019-01-25 | 2020-07-30 | Grail, Inc. | Detection d'un cancer, d'un tissu cancereux d'origine et/ou d'un type de cellule cancereuse |
| EP3921445B1 (fr) * | 2019-02-05 | 2024-09-04 | Grail, Inc. | Détection d'un cancer, d'un tissu cancéreux d'origine et/ou d'un type de cellule cancéreuse |
| CN109971860B (zh) * | 2019-04-30 | 2022-10-11 | 上海奕谱生物科技有限公司 | 基于甲基化修饰的肿瘤标记物stamp-ep8及其应用 |
| WO2020227100A1 (fr) * | 2019-05-03 | 2020-11-12 | Cornell University | Marqueurs pour l'identification et la quantification d'une mutation, d'une expression, d'un variant d'épissage, d'une translocation, d'un nombre de copies ou de changements de méthylation de séquence d'acides nucléiques |
| US11396679B2 (en) | 2019-05-31 | 2022-07-26 | Universal Diagnostics, S.L. | Detection of colorectal cancer |
| US20220251663A1 (en) * | 2019-06-14 | 2022-08-11 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Dna methylation biomarkers for cancer diagnosing and treatment |
| US11898199B2 (en) | 2019-11-11 | 2024-02-13 | Universal Diagnostics, S.A. | Detection of colorectal cancer and/or advanced adenomas |
| EP4083232A4 (fr) * | 2019-12-26 | 2024-03-20 | Anchordx Medical Co., Ltd. | Combinaison de biomarqueurs de méthylation de l'adn, et son procédé de détection et kit associé |
| US11851714B2 (en) | 2019-12-26 | 2023-12-26 | Anchordx Medical Co., Ltd. | Combinations, detection methods and kits of DNA methylation biomarker |
| CN110872631B (zh) * | 2019-12-26 | 2021-08-10 | 广州市基准医疗有限责任公司 | Dna甲基化生物标志物组合、检测方法和试剂盒 |
| CN117305461A (zh) * | 2019-12-31 | 2023-12-29 | 上海奕谱生物科技有限公司 | 新型的诊断肿瘤的标志物及其应用 |
| KR102637032B1 (ko) * | 2020-01-28 | 2024-02-15 | 주식회사 젠큐릭스 | 특정 유전자의 CpG 메틸화 변화를 이용한 방광암 진단용 조성물 및 이의 용도 |
| CN111635938B (zh) * | 2020-04-30 | 2022-07-29 | 广州康立明生物科技股份有限公司 | 一种肿瘤检测试剂及试剂盒 |
| WO2021228418A1 (fr) | 2020-05-15 | 2021-11-18 | Universal Diagnostics, S.L. | Méthodes et systèmes permettant d'identifier des biomarqueurs de méthylation |
| CN111560436A (zh) * | 2020-05-28 | 2020-08-21 | 郑成云 | 一种tert突变检测试剂盒及在肿瘤无创诊断中的应用 |
| US11530453B2 (en) * | 2020-06-30 | 2022-12-20 | Universal Diagnostics, S.L. | Systems and methods for detection of multiple cancer types |
| JP2024504603A (ja) * | 2021-01-12 | 2024-02-01 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | がんの診断および予後予測において使用するためのメチル化バイオマーカーの層解析 |
| WO2022255472A1 (fr) | 2021-06-03 | 2022-12-08 | 日本精工株式会社 | Procédé de détection de détérioration de graisse et procédé de détection de détérioration de lubrifiant |
| CN113652490B (zh) * | 2021-09-27 | 2022-07-22 | 广州凯普医药科技有限公司 | 一种用于膀胱癌早期筛查和/或预后监测的引物探针组合及试剂盒 |
| CN114107513B (zh) * | 2022-01-27 | 2022-05-03 | 北京优乐复生科技有限责任公司 | 一种用于膀胱尿路上皮癌诊断的检测方法和试剂盒 |
| CN116042820B (zh) * | 2022-09-07 | 2023-09-29 | 浙江大学 | 一组结肠癌dna甲基化分子标志物及其在制备用于结肠癌早期诊断试剂盒中的应用 |
| AU2023433294A1 (en) * | 2023-02-21 | 2025-09-25 | Nucleix Ltd. | Assessment of hematuria and other urinary tract symptoms |
| CN116287256A (zh) * | 2023-02-22 | 2023-06-23 | 苏州维基基因科技有限公司 | 用于膀胱癌早期诊断的检测试剂盒及其应用 |
| CN116987787B (zh) * | 2023-06-09 | 2024-07-30 | 北京泛生子基因科技有限公司 | 检测膀胱癌是否复发的装置和计算机可读存储介质 |
| CN116555432B (zh) * | 2023-07-05 | 2023-09-05 | 广州凯普医药科技有限公司 | 一种膀胱癌快速检测试剂盒 |
| CN118006781B (zh) * | 2024-02-27 | 2025-01-07 | 广州中鑫基因医学科技有限公司 | 用于检测尿路上皮癌的标志物、引物组、高敏感性和高特异性的试剂盒及检测方法 |
| CN118222710A (zh) * | 2024-03-25 | 2024-06-21 | 江苏阔然生物医药科技有限公司 | 检测dmrta2、runx3和twist1基因的甲基化水平的试剂在制备膀胱癌诊断产品中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010123354A2 (fr) * | 2009-04-20 | 2010-10-28 | Erasmus University Medical Center Rotterdam | Méthode de diagnostic du cancer de la vessie |
| US20120184447A1 (en) | 2009-06-26 | 2012-07-19 | Reinhold Wasserkort | Methods and Nucleic Acids for Analysis of Bladder Cell Proliferative Disorders |
| US9249467B2 (en) | 2011-09-16 | 2016-02-02 | Steven Goodison | Bladder cancer detection composition, kit and associated methods |
| US9096905B2 (en) | 2012-02-23 | 2015-08-04 | Medical Diagnostic Laboratories, Llc | Detecting DNA methylation of BCL2, CDKN2A and NID2 genes to predict bladder cancer in humans |
-
2015
- 2015-06-24 GB GBGB1511152.9A patent/GB201511152D0/en not_active Ceased
-
2016
- 2016-06-24 AU AU2016283063A patent/AU2016283063B2/en active Active
- 2016-06-24 CN CN201680048957.0A patent/CN108350504B/zh active Active
- 2016-06-24 WO PCT/GB2016/051903 patent/WO2016207656A1/fr not_active Ceased
- 2016-06-24 US US15/738,539 patent/US11473148B2/en active Active
- 2016-06-24 MA MA042238A patent/MA42238A/fr unknown
- 2016-06-24 JP JP2017567208A patent/JP7002334B2/ja active Active
- 2016-06-24 EP EP16732729.5A patent/EP3314016B1/fr active Active
-
2021
- 2021-10-15 JP JP2021169917A patent/JP2022025090A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3314016B1 (fr) | 2024-05-29 |
| JP2022025090A (ja) | 2022-02-09 |
| CN108350504A (zh) | 2018-07-31 |
| AU2016283063B2 (en) | 2022-01-20 |
| EP3314016A1 (fr) | 2018-05-02 |
| CN108350504B (zh) | 2023-09-29 |
| GB201511152D0 (en) | 2015-08-05 |
| WO2016207656A1 (fr) | 2016-12-29 |
| AU2016283063A1 (en) | 2018-02-08 |
| JP7002334B2 (ja) | 2022-02-04 |
| JP2018520672A (ja) | 2018-08-02 |
| US20180305765A1 (en) | 2018-10-25 |
| US11473148B2 (en) | 2022-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA42238A (fr) | Procédés de diagnostic du cancer de la vessie | |
| IL284172A (en) | Diagnostic methods for t cell therapy | |
| IL252796B (en) | Therapeutic, diagnostic and prognostic methods for cancer of the bladder | |
| EP3692164A4 (fr) | Marqueurs de méthylation pour le diagnostic du cancer | |
| EP3221340C0 (fr) | Procédé de diagnostic employant de la lipocaline neutrophile humaine (hnl) | |
| EP3288455C0 (fr) | Méthodes de diagnostic | |
| HUE051815T2 (hu) | Terápiás és diagnosztikai eljárások rákra | |
| IL240310A0 (en) | A non-invasive diagnostic method for the diagnosis of bladder cancer | |
| EP3307243A4 (fr) | Test de diagnostic pour le cancer à un stade précoce | |
| EP3630293A4 (fr) | Biomarqueurs de diagnostic du cancer du poumon | |
| GB201409479D0 (en) | Molecular diagnostic test for cancer | |
| IL256139B (en) | Bladder cancer diagnosis methods | |
| EP3623809A4 (fr) | Dispositif de diagnostic du cancer | |
| GB201608459D0 (en) | Diagnostic methods and kits | |
| GB201719423D0 (en) | Diagnostic tests | |
| EP3359696C0 (fr) | Test diagnostique pour surveillance urinaire du cancer de la vessie | |
| EP3427066A4 (fr) | Biomarqueurs lipidiques destinés au diagnostic du cancer | |
| EP3426241A4 (fr) | Procédés de diagnostic du cancer | |
| EP3690063C0 (fr) | Diagnostic du cancer du poumon | |
| GB201507827D0 (en) | Diagnostic test | |
| IL264542A (en) | Methods for gynecologic neoplasm diagnosis | |
| EP3289106A4 (fr) | Méthodes de diagnostic | |
| EP3607320A4 (fr) | Compositions et procédés de diagnostic du cancer du pancréas | |
| MA47259A (fr) | Diagnostic | |
| EP4013896A4 (fr) | Procédés protéogénomiques de diagnostic du cancer |